OABI
OmniAb Inc. Surpasses Expectations in Q3 2026, Announces Groundbreaking Partnerships
OmniAb Inc., a leading biotech company specializing in next-generation therapeutics discovery, has made significant strides in the third quarter of 2026. The company's recent conference call highlighted impressive achievements, including a major licensing deal with Eli Lilly and strong performance across various programs. During the conference call, Matt